Jane Street
WINT

Jane Street’s Windtree Therapeutics Inc WINT Stock Holding History

Jane Street’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,600
Closed -$41K – 3350
2014
Q3 		$41K Sell
1,600
-4,902
-75% -$118K ﹤0.01% 2437
2014
Q2 		$162K Sell
6,502
-1,803
-22% -$46.1K ﹤0.01% 2257
2014
Q1 		$250K Buy
+8,305
New +$279K ﹤0.01% 2151
2013
Q3 		– Sell
-5,634
Closed -$120K – 3378
2013
Q2 		$120K Buy
+5,634
New +$139K ﹤0.01% 2397

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Jane Street's WINT Position: Q4 2014 in Review

Jane Street sold out of Windtree Therapeutics Inc (WINT) in Q4 2014, closing a stake of 1,600 shares — an estimated $41K sold.

Jane Street first reported a position in WINT in Q2 2013 and held it in 4 quarters. The position peaked at $250K in Q1 2014. 56 funds tracked by Wall St. Rank hold WINT as of Q4 2014.

  • Jane Street reported no remaining Windtree Therapeutics Inc position as of Q4 2014 after selling out during the quarter.
  • Jane Street sold 1,600 Windtree Therapeutics Inc shares in Q4 2014, an estimated $41K.
  • Jane Street first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 4 quarters.
  • Jane Street's Windtree Therapeutics Inc position peaked at $250K in Q1 2014.
  • 56 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2014.

Based on Jane Street's 13F filing for Q4 2014, filed 17 Feb 2015.